01 / SIGNAL
MC4R-receptor activity
Literature describes binding at melanocortin-4 receptors expressed in hypothalamic neurons.
Melanocortin Agonist · Research Compound
PT
PT-141.
A melanocortin-receptor agonist research peptide (Bremelanotide). Literature describes activity at central nervous system melanocortin receptors (MC3R / MC4R) distinct from vascular-pathway compounds. Reference information only — not for human or animal consumption.
- Class
- Melanocortin Agonist
- Pathway
- Central / MC4R
- Route
- SubQ or Nasal
// 01About the compound
PT-141 (Bremelanotide) is a synthetic research peptide derived from melanotan II. Literature describes its activity as an agonist at the MC3R / MC4R melanocortin receptors expressed in the central nervous system.
Where PDE5-inhibitor literature concentrates on vascular signalling, melanocortin-receptor research examines a distinct central-nervous-system pathway. PT-141 is widely-studied as a tool compound for melanocortin-pathway research.
It is included in the Max Nutrition USA catalog as a current focus of melanocortin-pathway research literature.
// 02Mechanism — what the literature describes
Central nervous system pathway — different mechanism than every blood-flow alternative.
02 / RELEASE
Downstream signalling
Research examines downstream dopaminergic-pathway signalling endpoints.
03 / DISTINCT
Pathway-comparator research
Literature differentiates central melanocortin-pathway pharmacology from vascular PDE5-pathway research.
04 / OUTCOMES
CNS-pathway research
Trial data examines central-nervous-system signalling and behavioural-endpoint research models.
// 03Research focus areas
Central-pathway research
Literature examines central-nervous-system pathway activity distinct from peripheral vascular signalling.
Behavioural-endpoint research
Studies examine behavioural-endpoint dynamics in research models.
Mechanism-comparator literature
Examined alongside PDE5-inhibitor literature as a distinct pharmacological-pathway comparator.
Cross-population research
Trial data examines effects across male and female research populations.
Single-administration research
Pharmacokinetic literature examines single-administration dynamics rather than continuous-exposure studies.
Pharmacokinetic profile
Literature describes a 4–8 hour duration of effect in pharmacokinetic studies.
// 04Related research compounds
Endogenous GH research
CJC-1295 + Ipamorelin
Combined GHRH/GHRP research peptide; growth-hormone-pulse signalling literature.
View page → GHRH-analog researchTesamorelin
Stabilized GHRH-analog research peptide.
View page → Longevity researchNAD+ 500mg
Cellular-substrate research compound; longevity-pathway literature.
View page → Mitochondrial researchMOTS-C 40mg
Mitochondrial-derived peptide research; cellular-energy pathway literature.
View page →Research inquiries.
Direct line.
DM @max_nutritionusa for current PT-141 stock, pricing, CoA requests, and shipping. By contacting us you affirm you are a qualified researcher and will use any compound purchased strictly for laboratory research — not for human or animal consumption. We do not provide dosing or medical advice.
Disclaimer — Research Use Only
All products offered by Max Nutrition USA are sold strictly for in vitro laboratory research purposes only. Not for human or animal consumption. Not for diagnostic, therapeutic, or veterinary use.
These compounds have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease. They are not approved drugs, dietary supplements, or cosmetics under the Federal Food, Drug, and Cosmetic Act.
All content on this site — including product names, mechanism descriptions, and references to scientific literature — is provided for educational and informational purposes only. Nothing on this site constitutes medical, pharmaceutical, or dosing advice. Always consult a qualified, licensed healthcare professional before considering any application involving these or any other compounds.
Buyer attestation. By submitting an inquiry or placing an order, you represent and warrant that you are a qualified professional or researcher of legal age in your jurisdiction; that you will use these products solely for in vitro laboratory research; that you will not administer, ingest, inject, or otherwise consume any product purchased; and that you will handle, store, and dispose of all materials in accordance with all applicable federal, state, and local laws and regulations.
Max Nutrition USA does not provide dosing, administration, protocol, or medical advice through any channel, including direct messages, email, or phone. Any informal use-related questions will be declined.
Max Nutrition USA assumes no liability for misuse, improper handling, or use outside of a controlled research setting. The purchaser assumes all risks and responsibilities associated with the use, storage, and handling of these products.